Risks and benefits of anticoagulant therapy.
作者信息
Levine M N
出版信息
Semin Thromb Hemost. 1986 Jan;12(1):67-71. doi: 10.1055/s-2007-1003536.
PMID:3961508
Abstract
摘要
相似文献
1
Risks and benefits of anticoagulant therapy.
Semin Thromb Hemost. 1986 Jan;12(1):67-71. doi: 10.1055/s-2007-1003536.
2
Hemorrhagic complications of anticoagulant therapy.抗凝治疗的出血并发症。
Semin Thromb Hemost. 1986 Jan;12(1):39-57. doi: 10.1055/s-2007-1003533.
3
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.机械心脏瓣膜置换术、心房颤动或心肌梗死患者预防动脉血栓形成的口服抗凝治疗最佳水平：4202例患者的前瞻性研究
Arch Intern Med. 2009 Jul 13;169(13):1203-9. doi: 10.1001/archinternmed.2009.176.
4
Effectiveness of anticoagulants.抗凝剂的有效性。
Semin Thromb Hemost. 1986 Jan;12(1):21-37. doi: 10.1055/s-2007-1003532.
5
Risks of oral anticoagulant therapy with increasing age.随着年龄增长口服抗凝治疗的风险。
Arch Intern Med. 2005 Jul 11;165(13):1527-32. doi: 10.1001/archinte.165.13.1527.
6
[Current status of antithrombotic therapy].
Dtsch Med Wochenschr. 1995 Jan 27;120(4):105-10. doi: 10.1055/s-2008-1047737.
7
[Bleeding complications in oral anticoagulant treatment].
Nord Med. 1995;110(4):114-8.
8
Oral anticoagulant treatment with and without aspirin.
Thromb Haemost. 1995 Jul;74(1):506-10.
9
[Anticoagulation in aged patients with chronic non-rheumatic atrial fibrillation].
Med Clin (Barc). 1999 Mar 27;112(11):436-7.
Zotero 插件